Replimune Group, Inc. (REPL)
NASDAQ: REPL · Real-Time Price · USD
13.47
+0.60 (4.66%)
Sep 22, 2026, 4:00 PM EDT - Market closed
Replimune Group Market Cap
Replimune Group has a market cap or net worth of $1.27 billion as of September 22, 2026. Its market cap has increased by 404.23% in one year.
Market Cap
1.27B
Enterprise Value
1.19B
1-Year Change
404.23%
Ranking
Category
Stock Price
$13.47
ChartMarket Cap Chart
Since July 20, 2018, Replimune Group's market cap has increased from $467.50M to $1.27B, an increase of 171.47%. That is a compound annual growth rate of 12.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 1.27B | 66.44% |
| Dec 31, 2025 | 762.50M | -7.97% |
| Dec 31, 2024 | 828.50M | 66.40% |
| Dec 29, 2023 | 497.90M | -63.20% |
| Dec 30, 2022 | 1.35B | 6.46% |
| Dec 31, 2021 | 1.27B | -27.53% |
| Dec 31, 2020 | 1.75B | 281.78% |
| Dec 31, 2019 | 459.30M | 45.58% |
| Dec 31, 2018 | 315.50M | -32.51% |
| Jul 20, 2018 | 467.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Omeros | 1.34B |
| ORIC Pharmaceuticals | 1.31B |
| Vor Biopharma | 1.30B |
| MeiraGTx Holdings | 1.26B |
| Maze Therapeutics | 1.24B |
| Alto Neuroscience | 1.20B |
| Immatics | 1.19B |
| Aktis Oncology | 1.19B |